• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Wendy Y. Chen, MD, MPH


  • Farvid MS, Cho E, Chen WY, Eliassen AH, Willett WC.Dietary protein sources in early adulthood and breast cancer incidence: prospective cohort study.BMJ. 2014;348:g3437.
  • Boeke CE, Eliassen AH, Chen WY, Cho E, Holmes MD, Rosner B, Willett WC, Tamimi RM.Dietary fat intake in relation to lethal breast cancer in two large prospective cohort studies.Breast Cancer Res Treat. 2014 Jun 4.
  • Chen WY, Giobbie-Hurder A, Gantman K, Savoie J, Scheib R, Parker LM, Schernhammer ES.A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes.Breast Cancer Res Treat. 2014 Jun(2):381-8.
  • Farvid MS, Cho E, Chen WY, Eliassen AH, Willett WC.Premenopausal dietary fat in relation to pre- and post-menopausal breast cancer.Breast Cancer Res Treat. 2014 May;145(1):255-65.
  • Pierce JP, Patterson RE, Senger CM, Flatt SW, Caan BJ, Natarajan L, Nechuta SJ, Poole EM, Shu XO, Chen WY.Lifetime cigarette smoking and breast cancer prognosis in the After Breast Cancer Pooling Project.Journal of the National Cancer Institute. 2014 Jan;106(1):djt359.
  • Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ, Connolly JL, Chen WY, Willett WC, Tamimi RM.Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk.Journal of the National Cancer Institute. 2013 Oct 16;105(20):1571-8.
  • Nechuta S, Caan BJ, Chen WY, Kwan ML, Lu W, Cai H, Poole EM, Flatt SW, Zheng W, Pierce JP, Shu XO.Postdiagnosis cruciferous vegetable consumption and breast cancer outcomes: a report from the After Breast Cancer Pooling Project.Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1451-6.
  • Poole EM, Shu X, Caan BJ, Flatt SW, Holmes MD, Lu W, Kwan ML, Nechuta SJ, Pierce JP, Chen WY.Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project.Breast Cancer Res Treat. 2013 May 10.
  • Holmes MD, Hankinson SE, Feskanich D, Chen WY.Beta blockers and angiotensin-converting enzyme inhibitors' purported benefit on breast cancer survival may be explained by aspirin use.Breast Cancer Res Treat. 2013 May 7.
  • Rosner B, Glynn RJ, Tamimi RM, Chen WY, Colditz GA, Willett WC, Hankinson SE.Breast Cancer Risk Prediction with Heterogeneous Risk Profiles According to Breast Cancer Tumor Markers.Am J Epidemiol. 2013 May 3.
  • Holmes MD, Chen WY.Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality.Breast Cancer Res. 2012 Dec 10;14(2):216.
  • Kwan ML, Chen WY, Flatt SW, Weltzien EK, Nechuta S, Poole EM, Holmes M, Patterson RE, Shu XO, Pierce JP, Caan BJ.Post-diagnosis Alcohol Consumption and Breast Cancer Prognosis in the After Breast Cancer Pooling Project.Cancer Epidemiol Biomarkers Prev. 2012 Nov 13.
  • Mayer EL, Isakoff SJ, Klement G, Downing SR, Chen WY, Hannagan K, Gelman R, Winer EP, Burstein HJ.Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics.Breast Cancer Res Treat. 2012 Nov;136(1):169-78.
  • Caan BJ, Kwan ML, Shu XO, Pierce JP, Patterson RE, Nechuta SJ, Poole EM, Kroenke CH, Weltzien EK, Flatt SW, Quesenberry CP, Holmes MD, Chen WY.Weight change and survival after breast cancer in the after breast cancer pooling project.Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1260-71.
  • Nechuta SJ, Caan BJ, Chen WY, Lu W, Chen Z, Kwan ML, Flatt SW, Zheng Y, Zheng W, Pierce JP, Shu XO.Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women.Am J Clin Nutr. 2012 Jul;96(1):123-32.
  • Kotsopoulos J, Chen WY, Gates MA, Tworoger SS, Hankinson SE, Rosner BA.Risk factors for ductal and lobular breast cancer: results from the nurses' health study.Breast Cancer Res. 2010;12(6):R106.
  • Campos SM, Berlin ST, Parker LM, Chen WY, Bunnell CA, Atkinson T, Lee J, Matulonis U, Hirsch MS, Harris L, Krasner CN.Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer.Int J Clin Oncol. 2010 Aug;15(4):390-8.
  • Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE.Aspirin intake and survival after breast cancer.J Clin Oncol. 2010 Mar 20;28(9):1467-72.
  • Holmes MD, Chen WY, Hankinson SE, Willett WC.Physical activity's impact on the association of fat and fiber intake with survival after breast cancer.Am J Epidemiol. 2009 Nov 15;170(10):1250-6.
  • Kotsopoulos J,Tworoger SS,Devivo I,Hankinson SE,Hunter DJ,Willett WC,Chen WY.+331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer.Int J Cancer. 2009 Oct 1;125(7):1685-91.
  • Wilson KM,Mucci LA,Cho E,Hunter DJ,Chen WY,Willett WC.Dietary acrylamide intake and risk of premenopausal breast cancer.Am J Epidemiol. 2009 Apr 15;169(8):954-61.
  • Eliassen AH,Chen WY,Spiegelman D,Willett WC,Hunter DJ,Hankinson SE.Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II.Arch Intern Med. 2009 Jan 26;169(2):115-21; discussion 121.
  • Chen WY.Exogenous and endogenous hormones and breast cancer.Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):573-85. Review.
  • Ligibel JA, Campbell N, Partridge A, Chen WY, Salinardi T, Chen H, Adloff K, Keshaviah A, Winer EP.Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.J Clin Oncol. 2008 Feb 20;26(6):907-12.
  • Juszczynski P, Ouyang J, Monti S, Rodig SJ, Takeyama K, Abramson J, Chen W, Kutok JL, Rabinovich GA, Shipp MA.The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma.Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13134-9.
  • Lin CL, Liu CH, Chen W, Huang WL, Chen PJ, Lai MY, Chen DS, Kao JH.Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma.J Gastroenterol Hepatol. 2007 Jul;22(7):1098-103.
  • Chen WY, Colditz GA.Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer.Nat Clin Pract Oncol. 2007 Jul;4(7):415-23. Review.
  • Chen WY, Rosner B, Colditz GA.Moving forward with breast cancer prevention.Cancer. 2007 Jun 15;109(12):2387-91. Review.
  • Holmes MD, Murin S, Chen WY, Kroenke CH, Spiegelman D, Colditz GA.Smoking and survival after breast cancer diagnosis.Int J Cancer. 2007 Jun 15;120(12):2672-7.
  • Cho E, Chen WY, Hunter DJ, Stampfer MJ, Colditz GA, Hankinson SE, Willett WC.Red meat intake and risk of breast cancer among premenopausal women.Arch Intern Med. 2006 Nov 13;166(20):2253-9.
  • Tamimi RM, Hankinson SE, Chen WY, Rosner B, Colditz GA.Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.Arch Intern Med. 2006 Jul 24;166(14):1483-9.
  • Chen WY, Manson JE, Hankinson SE, Rosner B, Holmes MD, Willett WC, Colditz GA.Unopposed estrogen therapy and the risk of invasive breast cancer.Arch Intern Med. 2006 May 8;166(9):1027-32.
  • Kusano AS, Trichopoulos D, Terry KL, Chen WY, Willett WC, Michels KB.A prospective study of breast size and premenopausal breast cancer incidence.Int J Cancer. 2006 Apr 15;118(8):2031-4.
  • Chen WY, Bertone-Johnson ER, Hunter DJ, Willett WC, Hankinson SE.Associations between polymorphisms in the vitamin D receptor and breast cancer risk.Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2335-9.
  • Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE.Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1991-7.
  • Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA.Physical activity and survival after breast cancer diagnosis.JAMA. 2005 May 25;293(20):2479-86.
  • Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA.Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.Cancer. 2004 Oct 1;101(7):1490-500.
  • Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz GA, Holmes MD.Functional impact of breast cancer by age at diagnosis.J Clin Oncol. 2004 May 15;22(10):1849-56.
  • Al-Delaimy WK, Cho E, Chen WY, Colditz G, Willet WC.A prospective study of smoking and risk of breast cancer in young adult women.Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):398-404.
  • Chen WY, Manson JE.The Letrozole Breast Cancer Trial: clinical implications and remaining questions.Womens Health Issues. 2004 Jan-Feb;14(1):7-10.
  • Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE.Risk factors for breast cancer according to estrogen and progesterone receptor status.J Natl Cancer Inst. 2004 Feb 4;96(3):218-28.
  • Cho E, Spiegelman D, Hunter DJ, Chen WY, Colditz GA, Willett WC.Premenopausal dietary carbohydrate, glycemic index, glycemic load, and fiber in relation to risk of breast cancer.Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1153-8.
  • Colditz GA, Feskanich D, Chen WY, Hunter DJ, Willett WC.Physical activity and risk of breast cancer in premenopausal women.Br J Cancer. 2003 Sep 1;89(5):847-51.
  • Cho E, Spiegelman D, Hunter DJ, Chen WY, Zhang SM, Colditz GA, Willett WC.Premenopausal intakes of vitamins A, C, and E, folate, and carotenoids, and risk of breast cancer.Cancer Epidemiol Biomarkers Prev. 2003 Aug;12(8):713-20.
  • Cho E, Spiegelman D, Hunter DJ, Chen WY, Stampfer MJ, Colditz GA, Willett WC.Premenopausal fat intake and risk of breast cancer.J Natl Cancer Inst. 2003 Jul 16;95(14):1079-85.
  • Chen WY, Colditz GA, Rosner B, Hankinson SE, Hunter DJ, Manson JE, Stampfer MJ, Willett WC, Speizer FE.Use of postmenopausal hormones, alcohol, and risk for invasive breast cancer.Ann Intern Med. 2002 Nov 19;137(10):798-804.
  • Chen WY, Garber JE, Higham S, Schneider KA, Davis KB, Deffenbaugh AM, Frank TS, Gelman RS, Li FP.BRCA1/2 genetic testing in the community setting.J Clin Oncol. 2002 Nov 15;20(22):4485-92.